Event

Wandercraft secures €64.3 million in Series D funding

Jun 11, 2025 · Funding · Wandercraft · Healthcare

  • • Wandercraft secured €64.3 million in a Series D funding round on June 11, 2025.
  • • Investors included Renault Group, Bpifrance, the European Investment Bank, Teampact Ventures, and others.
  • • The funding will support the commercialization of their personal exoskeleton, Eve, and the development of the Calvin-40 humanoid robot.

Develops self-balancing robotic exoskeletons designed to restore walking ability for people with mobility impairments. The systems use dynamic stabilization to enable hands-free locomotion without crutches or walkers.

Segment
Healthcare
Event type
Funding
Geography
Paris · France